FeesSafety
Pluang+

Karman Holdings posts 66% revenue growth in Q3, eyes $1B sales next year amid strong backlog and order intake.

Company Fundamentals
10 Nov 2026, 17:57 WIB
Seeking Alpha
View Source
Bullish
Karman Holdings posts 66% revenue growth in Q3, eyes $1B sales next year amid strong backlog and order intake.

Karman Holdings reported a strong Q3 with 66% revenue growth, 25% organic growth, and a backlog increase of 108% to $1.7 billion. The company expects to maintain over 20% organic growth and aims to exceed $1 billion in sales next year, supported by robust order intake and long-term agreements. While leverage is high at 3.2x EBITDA, it remains manageable with refinancing options. Earnings per share are projected between $1 and $1.50 next year. Despite these positive fundamentals, caution is advised due to high valuations and potential political risks.

Karman Holdings is the subject of this report. For readers following Industrials-sector US stocks on Pluang, here is the market snapshot as of Nov 10, 2026 22:21 WIB: Of 135 priced stocks, 48 rose and 87 fell. Notable movers include GEO at USD 31.33 with a 3.95% gain and 100% sell order activity, AGCO at USD 111.93 down 3.94%, and TE at USD 2.20 down 3.93% with 86% buy order activity and a typical hold time of 2 days.

More News

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...

Others
Bullish
1 hour ago
Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...

Bullish
1 hour ago
New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...

Others
Bullish
2 hours ago
Global nucleic acid labeling market to hit $2.8B by 2032, driven by genomics and diagnostics growth.

Global nucleic acid labeling market to hit $2.8B by 2032, driven by genomics and diagnostics growth.

The global nucleic acid labeling market, valued at $1.7 billion in 2025, is projected to grow to $2.8 billion by 2032 at a 7% CAGR. Growth is fueled by advances in genomics, molecular diagnostics, and personalized medicine, with increasing demand for...

Market News
Bullish
2 hours ago
MonetizeMore launches AI tool to help publishers avoid Google AdSense bans.

MonetizeMore launches AI tool to help publishers avoid Google AdSense bans.

MonetizeMore introduced the AdSense Policy Grader, an AI-powered tool that audits websites for compliance with Google's ad policies to prevent account bans and revenue loss. The tool offers a free basic report and a detailed paid report covering 79 p...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App